Skip to main content

Market Overview

40 Healthcare Stocks Moving In Thursday's After-Market Session

Share:

Gainers

  • Aphria, Inc. (NYSE: APHA) shares moved upwards by 32.0% to $6.88 during Thursday's after-market session. The market cap stands at $1.3 B. According to the most recent rating by CIBC, on 2019-07-26, the current rating is at Underperformer.
  • Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares increased by 9.8% to $66.11. The market cap stands at $3.4 B. According to the most recent rating by SVB Leerink, on 2019-05-13, the current rating is at Outperform, with a price target of $83.00.
  • OpGen, Inc. (NASDAQ: OPGN) stock increased by 7.0% to $0.34. The market cap stands at $5.5 M.
  • Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares surged 6.8% to $10.94. The market cap stands at $215.8 M.
  • Endo International, Inc. (NASDAQ: ENDP) shares rose 6.2% to $3.24. The market cap stands at $689.8 M. According to the most recent rating by Morgan Stanley, on 2019-07-15, the current rating is at Underweight, with a price target of $3.00.
  • Insmed, Inc. (NASDAQ: INSM) shares rose 6.1% to $20.42. The market cap stands at $1.7 B.
  • Jaguar Health, Inc. (NASDAQ: JAGX) shares rose 5.6% to $1.70. The market cap stands at $8.9 M.
  • Coherus BioSciences, Inc. (NASDAQ: CHRS) stock surged 5.3% to $17.94. The market cap stands at $1.1 B. According to the most recent rating by Barclays, on 2019-06-11, the current rating is at Overweight, with a price target of $30.00.
  • OrganiGram Holdings, Inc. (NASDAQ: OGI) stock surged 5.3% to $5.95. The market cap stands at $881.6 M.
  • Geron, Inc. (NASDAQ: GERN) shares rose 5.2% to $1.21. The market cap stands at $214.4 M.
  • Trevena, Inc. (NASDAQ: TRVN) stock rose 5.0% to $0.97. The market cap stands at $84.9 M. According to the most recent rating by H.C. Wainwright, on 2019-05-31, the current rating is at Buy, with a price target of $3.50.
  • VBI Vaccines, Inc. (NASDAQ: VBIV) stock increased by 5.0% to $0.73. The market cap stands at $67.5 M.
  • Cara Therapeutics, Inc. (NASDAQ: CARA) shares surged 4.6% to $23.94. The market cap stands at $1.0 B. According to the most recent rating by Piper Jaffray, on 2019-07-30, the current rating is at Overweight, with a price target of $39.00.
  • Puma Biotechnology, Inc. (NASDAQ: PBYI) stock increased by 4.6% to $9.85. The market cap stands at $363.7 M. According to the most recent rating by Cantor Fitzgerald, on 2019-05-10, the current rating is at Neutral, with a price target of $20.00.
  • Adaptimmune Therapeutics, Inc. (NASDAQ: ADAP) stock rose 4.5% to $3.08. The market cap stands at $308.9 M. According to the most recent rating by Roth Capital, on 2019-05-31, the current rating is at Buy, with a price target of $7.00.
  • Acasti Pharma, Inc. (NASDAQ: ACST) stock rose 4.4% to $2.59. The market cap stands at $196.4 M. According to the most recent rating by Oppenheimer, on 2019-07-18, the current rating is at Outperform, with a price target of $7.00.
  • CareDx, Inc. (NASDAQ: CDNA) stock moved upwards by 4.4% to $35.50. The market cap stands at $1.4 B. According to the most recent rating by H.C. Wainwright, on 2019-05-09, the current rating is at Buy, with a price target of $43.00.
  • Athersys, Inc. (NASDAQ: ATHX) shares surged 4.3% to $1.45. The market cap stands at $208.1 M.
  • Kindred Biosciences, Inc. (NASDAQ: KIN) stock increased by 4.2% to $7.25. The market cap stands at $271.4 M. According to the most recent rating by B. Riley, on 2019-07-16, the current rating is at Neutral, with a price target of $8.50.
  • Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) stock rose 4.2% to $5.50. The market cap stands at $19.7 M.
  • Cronos Group, Inc. (NASDAQ: CRON) shares rose 4.1% to $13.25. The market cap stands at $4.2 B. According to the most recent rating by Consumer Edge, on 2019-06-28, the current rating is at Equal-Weight.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) shares surged 3.8% to $0.60. The market cap stands at $25.7 M. According to the most recent rating by Alliance Global Partners, on 2019-08-01, the current rating is at Neutral, with a price target of $0.40.
  • Aurora Cannabis, Inc. (NYSE: ACB) stock moved upwards by 3.8% to $6.07. The market cap stands at $5.9 B. According to the most recent rating by Bank of America, on 2019-07-18, the current rating is at Neutral.
  • Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares rose 3.7% to $6.17. The market cap stands at $201.6 M.
  • Benitec Biopharma, Inc. (NASDAQ: BNTC) shares rose 3.7% to $0.85. The market cap stands at $10.3 M.

 

Losers

  • Correvio Pharma, Inc. (NASDAQ: CORV) shares decreased by 13.5% to $1.60 during Thursday's after-market session. The market cap stands at $73.7 M.
  • Agile Therapeutics, Inc. (NASDAQ: AGRX) stock declined 11.8% to $0.97. The market cap stands at $48.1 M. According to the most recent rating by Oppenheimer, on 2019-06-07, the current rating is at Outperform, with a price target of $5.00.
  • Fluidigm, Inc. (NASDAQ: FLDM) shares plummeted 11.0% to $10.81. The market cap stands at $838.5 M.
  • CannTrust Holdings, Inc. (NYSE: CTST) shares plummeted 11.0% to $1.94. The market cap stands at $307.0 M. According to the most recent rating by Roth Capital, on 2019-07-09, the current rating is at Neutral.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stock decreased by 7.1% to $23.39. The market cap stands at $3.1 B.
  • Zafgen, Inc. (NASDAQ: ZFGN) shares declined 5.8% to $0.97. The market cap stands at $38.4 M.
  • ENDRA Life Sciences, Inc. (NASDAQ: NDRA) stock declined 4.9% to $1.35. The market cap stands at $10.5 M. According to the most recent rating by H.C. Wainwright, on 2019-07-15, the current rating is at Buy, with a price target of $6.00.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) stock decreased by 4.1% to $4.70. The market cap stands at $209.9 M. According to the most recent rating by Cowen & Co., on 2019-05-21, the current rating is at Market Perform.
  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) stock declined 3.5% to $25.04. The market cap stands at $863.9 M.
  • Editas Medicine, Inc. (NASDAQ: EDIT) stock fell 3.0% to $25.00. The market cap stands at $1.2 B.
  • Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares declined 2.9% to $4.71. The market cap stands at $17.2 M.
  • SINTX Technologies, Inc. (NASDAQ: SINT) stock decreased by 2.8% to $2.45. The market cap stands at $1.8 M.
  • Avrobio, Inc. (NASDAQ: AVRO) shares fell 2.2% to $20.00. The market cap stands at $493.8 M. According to the most recent rating by Mizuho, on 2019-06-27, the current rating is at Buy, with a price target of $28.00.
  • Sarepta Therapeutics, Inc. (NASDAQ: SRPT) shares declined 2.0% to $145.00. The market cap stands at $10.9 B. According to the most recent rating by Morgan Stanley, on 2019-07-09, the current rating is at Overweight, with a price target of $220.00.
  • Biomarin Pharmaceutical, Inc. (NASDAQ: BMRN) stock decreased by 2.0% to $79.35. The market cap stands at $14.5 B.
 

Related Articles (ACST + ACB)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks After-Market MoversNews Movers & Shakers After-Hours Center Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com